Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Aktie
19,80 €
2,59 %
Die Community liebt Ultragenyx Pharmaceutical Inc.: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Community-Kursziel von 55 € für Ultragenyx Pharmaceutical Inc. zeigt eine potenzielle Verdopplung im Vergleich zum aktuellen Kurs von 19.8 €.
